GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharma Advanced Research Co Ltd (BOM:532872) » Definitions » 6-1 Month Momentum %

Sun Pharma Advanced Research Co (BOM:532872) 6-1 Month Momentum % : -28.95% (As of Apr. 24, 2025)


View and export this data going back to 2007. Start your Free Trial

What is Sun Pharma Advanced Research Co 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2025-04-24), Sun Pharma Advanced Research Co's 6-1 Month Momentum % is -28.95%.

The industry rank for Sun Pharma Advanced Research Co's 6-1 Month Momentum % or its related term are showing as below:

BOM:532872's 6-1 Month Momentum % is ranked worse than
84.82% of 1054 companies
in the Drug Manufacturers industry
Industry Median: -6.31 vs BOM:532872: -28.95

Competitive Comparison of Sun Pharma Advanced Research Co's 6-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharma Advanced Research Co's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sun Pharma Advanced Research Co's 6-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sun Pharma Advanced Research Co's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Sun Pharma Advanced Research Co's 6-1 Month Momentum % falls into.


;
;

Sun Pharma Advanced Research Co  (BOM:532872) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sun Pharma Advanced Research Co  (BOM:532872) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Sun Pharma Advanced Research Co 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Sun Pharma Advanced Research Co's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sun Pharma Advanced Research Co Business Description

Traded in Other Exchanges
Address
Off Mahakali Caves Road, 17-B, Mahal Industrial Estate, Andheri (East), Mumbai, MH, IND, 400093
Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in othe4r countries.

Sun Pharma Advanced Research Co Headlines

No Headlines